Effects of silymarin on the proliferation and glutathione levels of peripheral blood mononuclear cells from β-thalassemia major patients

International Immunopharmacology

Volumn 6, Issue 8, 2006, Pages 1305-1310

  Alidoost, Fariba ^a   Gharagozloo, Marjan ^a   Bagherpour, Bahram ^a   Jafarian, Abbas ^b   Sajjadi, Seyed Ebrahim ^c   Hourfar, Hamid ^d   Moayedi, Behjat ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

thalassemia major; Glutathione; Immune response; Oxidative stress; Silybum marianum; Silymarin

Indexed keywords

FLAVANOID; GLUTATHIONE; SILYMARIN;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CELL ACTIVATION; CELL LEVEL; CELL PROLIFERATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; INCUBATION TIME; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTIOXIDANTS; BETA-THALASSEMIA; BROMODEOXYURIDINE; CELL PROLIFERATION; CELLS, CULTURED; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; HUMANS; LEUKOCYTES, MONONUCLEAR; PHYTOHEMAGGLUTININS; SILYMARIN; TIME FACTORS;

EID: 33744980639     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.04.004     Document Type: Article

References (29)

1. Kassab-Chekir A., Laradi S., Ferchichi S., Haj Khelil A., Feki M., Amri F., et al. Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta 338 (2003) 79-86
2. Schrier S.L., Centis F., Verneris M., Ma L., and Angelucci E. The role of oxidant injury in the pathophysiology of human thalassemias. Redox Rep 8 (2003) 241-245
3. Cighetti G., Duca L., Bortone L., Sala S., Nava I., Fiorelli G., et al. Oxidative status and malondialdehyde in beta-thalassaemia patients. Eur J Clin Invest 32 (2002) 55-60
4. Chakraborty D., and Bhattacharyya M. Antioxidant defense status of red blood cells of patients with beta-thalassemia and Ebeta-thalassemia. Clin Chim Acta 305 (2001) 123-129
5. Walker Jr. E.M., and Walker S.M. Effects of iron overload on the immune system. Ann Clin Lab Sci 30 (2000) 354-365
6. Weiss G. Iron and immunity: a double-edged sword. Eur J Clin Invest 32 (2002) 70-78
7. Cunningham-Rundles S., Giardina P.J., Grady R.W., Califano C., McKenzie P., and De Sousa M. Effect of transfusional iron overload on immune response. J Infect Dis 182 (2000) S115-S121
8. Farmakis D., Giakoumis A., Aessopos A., and Polymeropoulos E. Pathogenetic aspects of immune deficiency associated with beta-thalassemia. Med Sci Monit 9 (2003) RA19-RA22
9. Santangelo F. Intracellular thiol concentration modulating inflammatory response: influence on the regulation of cell functions through cysteine prodrug approach. Curr Med Chem 10 (2003) 2599-2610
10. Kabe Y., Ando K., Hirao S., Yoshida M., and Handa H. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7 (2005) 395-403
11. Townsend D.M., Tew K.D., and Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother 57 (2003) 145-155
12. Droge W., and Breitkreutz R. Glutathione and immune function. Proc Nutr Soc 59 (2000) 595-600
13. Valenzuela A., and Garrido A. Biochemical bases of the pharmacological action of the flavonoid silymarin and of its structural isomer silibinin. Biol Res 27 (1994) 105-112
14. Valenzuela A., Aspillaga M., Vial S., and Guerra R. Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat. Planta Med 55 (1989) 420-422
15. Borsari M., Gabbi C., Ghelfi F., Grandi R., Saladini M., Severi S., et al. Silybin, a new iron-chelating agent. J Inorg Biochem 85 (2001) 123-129
16. Dietzmann J., Thiel U., Ansorge S., Neumann K.H., and Tager M. Thiol-inducing and immunoregulatory effects of flavonoids in peripheral blood mononuclear cells from patients with end-stage diabetic nephropathy. Free Radic Biol Med 33 (2002) 1347-1354
17. Wilasrusmee C., Kittur S., Shah G., Siddiqui J., Bruch D., Wilasrusmee S., et al. Immunostimulatory effect of Silybum marianum (milk thistle) extract. Med Sci Monit 8 (2002) BR439-BR443
18. Lang I., Nekam K., Deak G., Muzes G., Gonzales-Cabello R., Gergely P., et al. Immunomodulatory and hepatoprotective effects of in vivo treatment with free radical scavengers. Ital J Gastroenterol 22 (1990) 283-287
19. Lang I., Deak G., Nekam K., Muzes G., Gonzalez-Cabello R., Gergely P., et al. Hepatoprotective and immunomodulatory effects of antioxidant therapy. Acta Med Hung 45 (1988) 287-295
20. Hirshaut Y., Weiss G.H., and Perry S. The use of long-term human leukocyte cell cultures as models for the study of antileukemic agents. Cancer Res 29 (1969) 1732-1740
21. Lands L.C., Grey V., Smountas A.A., Kramer V.G., and McKenna D. Lymphocyte glutathione levels in children with cystic fibrosis. Chest 116 (1999) 201-205
22. Baker M.A., Cerniglia G.J., and Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 190 (1990) 360-365
23. Kavanagh T.J., Grossmann A., Jaecks E.P., Jinneman J.C., Eaton D.L., Martin G.M., et al. Proliferative capacity of human peripheral blood lymphocytes sorted on the basis of glutathione content. J Cell Physiol 145 (1990) 472-480
24. Peterson J.D., Herzenberg L.A., Vasquez K., and Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci U S A 95 (1998) 3071-3076
25. Rimbach G., Gohil K., Matsugo S., Moini H., Saliou C., Virgili F., et al. Induction of glutathione synthesis in human keratinocytes by Ginkgo biloba extract (EGb761). Biofactors 15 (2001) 39-52
26. Moskaug J.O., Carlsen H., Myhrstad M.C., and Blomhoff R. Polyphenols and glutathione synthesis regulation. Am J Clin Nutr 81 (2005) 277S-283S
27. Wu G., Fang Y.Z., Yang S., Lupton J.R., and Turner N.D. Glutathione metabolism and its implications for health. J Nutr 134 (2004) 489-492
28. Griffith O.W. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 27 (1999) 922-935
29. Manna S.K., Mukhopadhyay A., Van N.T., and Aggarwal B.B. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. J Immunol 163 (1999) 6800-6809